Press Release

Medtronic Introduces ANCHOR FS Facet Fixation System

MEMPHIS, Tenn. – Oct. 23, 2012 – Medtronic, Inc. (NYSE: MDT) the world leader in spinal technology, announced today the latest addition to their minimally invasive spinal fusion portfolio at the 27th annual meeting of the North American Spine Society in Dallas.

The ANCHOR FS™ Facet Fixation System is a minimally invasive posterior screw system used in the lumbar region of the spine. It is intended to provide stability by fixation through the facet joints. The ANCHOR FS™ Facet Fixation System includes a streamlined, single-use sterile packed instrument set with a variety of cannulated screw options to accommodate varying patient anatomy. 

The ANCHOR FS™ Facet Fixation System is indicated for posterior surgical treatment of any or all of the following in the lumbar region of the spine, at single or multiple levels:

  • Trauma, including spinal fractures and/or dislocations;
  • Spondylolisthesis;
  • Spondylolysis;
  • Pseudoarthrosis or failed previous fusions which are symptomatic or which may cause secondary instability or deformity;
  • Degenerative disc disease (DDD) as defined by back pain of discogenic origin as confirmed by patient history with degeneration of the disc as confirmed by radiographic studies.
  • Degenerative disease of the facets with instability.

The ANCHOR FS™ Facet Fixation System is intended to stabilize the spine as an aid to lumbar fusion by providing bilateral facet fixation, with or without bone graft. It is the latest technology in a series of therapies that compliments Medtronic Spinal’s minimally invasive MAST® portfolio to successfully treat patients for a variety of degenerative and deformity spinal conditions. In the United States, over 250,000 individuals undergo spinal fusions annually to treat degenerative changes in the lumbar spine.

About Minimally Invasive Spinal Surgery vs. Traditional Open-Back Surgery

  • Minimally invasive surgery requires a smaller incision than traditional open-back surgery, leaving patients with smaller scars.
  • Minimally invasive surgery has been reported to minimize cutting of  muscles, tendons, and other normal tissues that aren’t directly involved with the back disorders.1
  • One of the risks associated with MIS is the possibility of converting to an open procedure.

About Medtronic’s Spinal Business
Medtronic’s spinal business, based in Memphis, Tenn., is the global leader in today’s spine market and is committed to advancing the treatment of spinal conditions. Medtronic’s spinal business collaborates with world-renowned surgeons, researchers and innovative partners to offer state-of-the-art therapies for spinal, neurological, orthopaedic and oral maxillofacial conditions. Medtronic is committed to developing affordable, minimally invasive procedures that provide lifestyle friendly surgical therapies.

About Medtronic
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

-end-

1 Isaacs. Minimally invasive microendoscopy-assisted transforaminal lumbar interbody fusion. J. Neruosurg: Spine. 3:98-105, 2005.

Medtronic Media Contacts:
Victor Rocha, Public Relations, 901-399-2401
Jeff Warren, Investor Relations, 763-505-2696
X